US Stock MarketDetailed Quotes

CNS Pharmaceuticals (CNSP)

Watchlist
  • 7.370
  • +1.170+18.87%
Close Jan 15 16:00 ET
  • 6.840
  • -0.530-7.19%
Post 20:01 ET
4.57MMarket Cap-0.32P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CNS Pharmaceuticals (CNSP) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments
41.46%9.86M
713.23%12.13M
1,500.49%13.05M
1,077.53%6.46M
1,077.53%6.46M
666.66%6.97M
-65.14%1.49M
-84.05%815.23K
-94.54%548.72K
-94.54%548.72K
-Cash and cash equivalents
41.46%9.86M
713.23%12.13M
1,500.49%13.05M
1,077.53%6.46M
1,077.53%6.46M
666.66%6.97M
-65.14%1.49M
-84.05%815.23K
-94.54%548.72K
-94.54%548.72K
Receivables
--0
--0
--0
--882.54K
--882.54K
----
----
----
--0
--0
-Accounts receivable
--0
--0
--0
--882.54K
--882.54K
----
----
----
--0
--0
Current deferred assets
62.26%43.7K
-15.39%14.17K
--20.64K
-89.83%20.64K
-89.83%20.64K
--26.93K
--16.75K
--0
--202.86K
--202.86K
Other current assets
282.42%1.48M
212.95%1.99M
-16.83%653.8K
54.12%1.29M
54.12%1.29M
-66.32%388.04K
-64.44%637.09K
-57.78%786.05K
-66.54%839.59K
-66.54%839.59K
Total current assets
54.19%11.39M
558.98%14.14M
756.94%13.72M
444.16%8.66M
444.16%8.66M
258.32%7.39M
-64.66%2.15M
-77.03%1.6M
-87.34%1.59M
-87.34%1.59M
Non current assets
Net PPE
10.89%3.11K
7.06%3.8K
13.94%4.91K
21.73%6.01K
21.73%6.01K
-19.25%2.8K
5.06%3.55K
-1.82%4.31K
-12.91%4.93K
-12.91%4.93K
Non current prepaid assets
2,482.14%474.42K
14.34%366.25K
-59.52%22.38K
-65.22%36.43K
-65.22%36.43K
-93.01%18.37K
-15.08%320.32K
-87.38%55.3K
-78.30%104.75K
-78.30%104.75K
Total non current assets
2,155.13%477.52K
14.26%370.06K
-54.21%27.29K
-61.31%42.44K
-61.31%42.44K
-92.05%21.18K
-14.90%323.87K
-86.53%59.6K
-77.55%109.68K
-77.55%109.68K
Total assets
60.19%11.87M
487.54%14.51M
727.83%13.75M
411.56%8.7M
411.56%8.7M
218.26%7.41M
-61.73%2.47M
-77.60%1.66M
-86.97%1.7M
-86.97%1.7M
Liabilities
Current liabilities
Current debt and capital lease obligation
-1.26%30.79K
-1.20%121.77K
-1.14%210.67K
8.40%326.07K
8.40%326.07K
-25.58%31.19K
-25.93%123.25K
-26.28%213.1K
-26.63%300.81K
-26.63%300.81K
-Current debt
-1.26%30.79K
-1.20%121.77K
-1.14%210.67K
8.40%326.07K
8.40%326.07K
-25.58%31.19K
-25.93%123.25K
-26.28%213.1K
-26.63%300.81K
-26.63%300.81K
Current liabilities
-51.71%1.96M
-79.55%1.38M
-54.38%2.78M
-58.84%2.52M
-58.84%2.52M
-0.29%4.06M
69.19%6.76M
55.28%6.09M
24.65%6.13M
24.65%6.13M
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
-51.71%1.96M
-79.55%1.38M
-54.38%2.78M
-58.84%2.52M
-58.84%2.52M
-0.29%4.06M
69.19%6.76M
55.28%6.09M
24.65%6.13M
24.65%6.13M
Shareholders'equity
Share capital
-98.28%574
-65.07%504
-72.40%2.95K
70,600.00%1.41K
70,600.00%1.41K
695.01%33.45K
-65.15%1.44K
379.29%10.67K
-99.88%2
-99.88%2
-common stock
-98.28%574
-65.07%504
-72.40%2.95K
70,600.00%1.41K
70,600.00%1.41K
695.01%33.45K
-65.15%1.44K
379.29%10.67K
-99.88%2
-99.88%2
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-16.09%-94.32M
-20.44%-91.1M
-21.36%-88.73M
-21.36%-84.42M
-21.36%-84.42M
-26.57%-81.25M
-26.77%-75.64M
-31.38%-73.11M
-37.17%-69.57M
-37.17%-69.57M
Paid-in capital
23.25%104.23M
46.08%104.23M
45.18%99.69M
39.10%90.6M
39.10%90.6M
35.42%84.57M
14.86%71.35M
16.12%68.67M
10.69%65.13M
10.69%65.13M
Total stockholders'equity
195.62%9.91M
405.69%13.12M
347.60%10.97M
239.36%6.18M
239.36%6.18M
292.58%3.35M
-274.93%-4.29M
-226.88%-4.43M
-154.50%-4.43M
-154.50%-4.43M
Total equity
195.62%9.91M
405.69%13.12M
347.60%10.97M
239.36%6.18M
239.36%6.18M
292.58%3.35M
-274.93%-4.29M
-226.88%-4.43M
-154.50%-4.43M
-154.50%-4.43M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments 41.46%9.86M713.23%12.13M1,500.49%13.05M1,077.53%6.46M1,077.53%6.46M666.66%6.97M-65.14%1.49M-84.05%815.23K-94.54%548.72K-94.54%548.72K
-Cash and cash equivalents 41.46%9.86M713.23%12.13M1,500.49%13.05M1,077.53%6.46M1,077.53%6.46M666.66%6.97M-65.14%1.49M-84.05%815.23K-94.54%548.72K-94.54%548.72K
Receivables --0--0--0--882.54K--882.54K--------------0--0
-Accounts receivable --0--0--0--882.54K--882.54K--------------0--0
Current deferred assets 62.26%43.7K-15.39%14.17K--20.64K-89.83%20.64K-89.83%20.64K--26.93K--16.75K--0--202.86K--202.86K
Other current assets 282.42%1.48M212.95%1.99M-16.83%653.8K54.12%1.29M54.12%1.29M-66.32%388.04K-64.44%637.09K-57.78%786.05K-66.54%839.59K-66.54%839.59K
Total current assets 54.19%11.39M558.98%14.14M756.94%13.72M444.16%8.66M444.16%8.66M258.32%7.39M-64.66%2.15M-77.03%1.6M-87.34%1.59M-87.34%1.59M
Non current assets
Net PPE 10.89%3.11K7.06%3.8K13.94%4.91K21.73%6.01K21.73%6.01K-19.25%2.8K5.06%3.55K-1.82%4.31K-12.91%4.93K-12.91%4.93K
Non current prepaid assets 2,482.14%474.42K14.34%366.25K-59.52%22.38K-65.22%36.43K-65.22%36.43K-93.01%18.37K-15.08%320.32K-87.38%55.3K-78.30%104.75K-78.30%104.75K
Total non current assets 2,155.13%477.52K14.26%370.06K-54.21%27.29K-61.31%42.44K-61.31%42.44K-92.05%21.18K-14.90%323.87K-86.53%59.6K-77.55%109.68K-77.55%109.68K
Total assets 60.19%11.87M487.54%14.51M727.83%13.75M411.56%8.7M411.56%8.7M218.26%7.41M-61.73%2.47M-77.60%1.66M-86.97%1.7M-86.97%1.7M
Liabilities
Current liabilities
Current debt and capital lease obligation -1.26%30.79K-1.20%121.77K-1.14%210.67K8.40%326.07K8.40%326.07K-25.58%31.19K-25.93%123.25K-26.28%213.1K-26.63%300.81K-26.63%300.81K
-Current debt -1.26%30.79K-1.20%121.77K-1.14%210.67K8.40%326.07K8.40%326.07K-25.58%31.19K-25.93%123.25K-26.28%213.1K-26.63%300.81K-26.63%300.81K
Current liabilities -51.71%1.96M-79.55%1.38M-54.38%2.78M-58.84%2.52M-58.84%2.52M-0.29%4.06M69.19%6.76M55.28%6.09M24.65%6.13M24.65%6.13M
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities -51.71%1.96M-79.55%1.38M-54.38%2.78M-58.84%2.52M-58.84%2.52M-0.29%4.06M69.19%6.76M55.28%6.09M24.65%6.13M24.65%6.13M
Shareholders'equity
Share capital -98.28%574-65.07%504-72.40%2.95K70,600.00%1.41K70,600.00%1.41K695.01%33.45K-65.15%1.44K379.29%10.67K-99.88%2-99.88%2
-common stock -98.28%574-65.07%504-72.40%2.95K70,600.00%1.41K70,600.00%1.41K695.01%33.45K-65.15%1.44K379.29%10.67K-99.88%2-99.88%2
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -16.09%-94.32M-20.44%-91.1M-21.36%-88.73M-21.36%-84.42M-21.36%-84.42M-26.57%-81.25M-26.77%-75.64M-31.38%-73.11M-37.17%-69.57M-37.17%-69.57M
Paid-in capital 23.25%104.23M46.08%104.23M45.18%99.69M39.10%90.6M39.10%90.6M35.42%84.57M14.86%71.35M16.12%68.67M10.69%65.13M10.69%65.13M
Total stockholders'equity 195.62%9.91M405.69%13.12M347.60%10.97M239.36%6.18M239.36%6.18M292.58%3.35M-274.93%-4.29M-226.88%-4.43M-154.50%-4.43M-154.50%-4.43M
Total equity 195.62%9.91M405.69%13.12M347.60%10.97M239.36%6.18M239.36%6.18M292.58%3.35M-274.93%-4.29M-226.88%-4.43M-154.50%-4.43M-154.50%-4.43M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -